ArticleScientific reports2025
Revolutionizing AMD detection Bi model CNNs and hybrid feature selection for automated grading.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Age-related macular degeneration (AMD) is a common cause of vision loss in older adults. The automated grading of AMD from fundus images can aid in early detection and treatment. In this research, we propose a comprehensive framework that can enhance the quality of fundus images and increase automated grading accuracy. We employ preprocessing techniques such as the Adaptive Contrast Enhancement Algorithm (CLAHE) and Gamma correction to improve image quality and feature representation. Additionally, we suggest a hybrid feature selection approach that combines handcrafted and deep learning-based features to identify discriminative features for AMD grading. This approach can comprehensively represent AMD-related abnormalities, leaving no room for ambiguity. Furthermore, we introduce a new Bi-Model Convolutional Neural Network (CNN) architecture that uses global and local features for accurate AMD grading. The Bi-Model CNN integrates feature representations extracted from the entire fundus image and local patches to capture global context and fine-grained details. This approach offers precise, consistent, and prompt results, thereby increasing the effectiveness of early disease identification. Experimental results demonstrate that the Bi-CNN + Feature Fusion model achieves a 99.5% accuracy, outperforming other configurations. The model's performance is further validated with high precision (0.995), recall (0.995), and F1-score (0.995), along with a Cohen's Kappa of 0.990, indicating almost perfect agreement between predicted and actual labels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.